Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis have?
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis has 166 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis published?
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis has 2013 year in the ScholarIQ index.
What is the open-access status of Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis?
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis has hybrid oa status in the ScholarIQ index.
What is the DOI of Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis?
The DOI for Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis is on the source record.
What is the PMID of Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis?
The PMID for Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis is on the source record.
What is the OpenAlex record for Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis?
The OpenAlex for Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis is on the source record.